15/08/2024
Check your inbox! This week's Pharmacy Angle Rx Insights Newsletter covers the latest in transformative pharmacy leadership and technology. Our in-depth articles discuss the shift of pharmacy departments into specialty and telehealth services, as well as a systemic approach to integrating pharmacy technology. We also feature an executive interview with Arash Dabestani, offering perspectives on leadership and innovation. In industry news, the FDA has approved the first nasal spray for anaphylaxis treatment, B. Braun has issued a nationwide recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers, and Vertex's Suzetrigine NDA for acute pain has gained FDA acceptance. Additionally, a new test is now available to detect patients' risk of harmful side effects from Alzheimer's drugs. In our Partner Voice section, learn how AZO® Products are addressing urinary tract and vaginal health issues.
If you're not currently receiving our bi-monthly Rx Insights, be sure to sign up for news delivered right to your inbox.